Clinical trial
Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma : A Comparative, Randomized, Controlled Study
NCT07034560 is registered in ClinicalTrials.gov with Thammasat University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma : A Comparative, Randomized, Controlled Study
- Lead sponsor
- Thammasat University
- Phase
- Phase 4
- Overall status
- Active, not recruiting
- Start date
- November 12, 2024
- Completion date
- November 6, 2025
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
melasma, recurrence, treatment outcome